Filed with the SEC as Schwab Andrew J.; the order above is the one the filer's own signature uses.
In the 12 months to Nov 8, 2026, on the open market: sold $2.9M of CAMP, SKYE. Filed a median of 2 business days after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $0Insider sales below: $2.9M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
CAMPSold: Camp4 Therapeutics Corp Aug 27, 2026400,000 sharesfiled Aug 31, 20262,033,270 shares held indirectly after, as filedfiling$1.6M
CAMPSold: Camp4 Therapeutics Corp Aug 24, 202610 sharesfiled Aug 26, 20262,433,270 shares held indirectly after, as filedfiling$45
CAMPSold: Camp4 Therapeutics Corp Aug 21, 202632,018 sharesfiled Aug 21, 20262,433,280 shares held indirectly after, as filedfiling$144K
CAMPSold: Camp4 Therapeutics Corp Aug 20, 2026114,700 sharesfiled Aug 21, 20262,465,298 shares held indirectly after, as filedfiling$521K
SKYESold: Skye Bioscience, Inc. Aug 20, 20267,700 sharesfiled Aug 20, 20263 transactionsfiling$2K
CAMPSold: Camp4 Therapeutics Corp Aug 19, 202645,147 sharesfiled Aug 21, 20262,579,998 shares held indirectly after, as filedfiling$215K
SKYESold: Skye Bioscience, Inc. Aug 19, 202668,140 sharesfiled Aug 20, 20263 transactionsfiling$24K
SKYESold: Skye Bioscience, Inc. Aug 18, 2026300,000 sharesfiled Aug 20, 20263 transactionsfiling$114K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
